Exagen Inc.

3.01
-0.45 (-13.01%)
At close: Mar 03, 2025, 3:59 PM
2.80
-6.82%
After-hours: Mar 03, 2025, 05:57 PM EST

Exagen Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY15 FY14 FY13 FY12
Net Income -23.69M -47.39M -26.85M -16.69M -12.04M -8.01M -25.63M -19.18M -14.98M -13.5M -7.32M
Depreciation & Amortization 2.17M 1.56M 948K 546K 591K 731K 670K 879K 558K 455K 398K
Stock-Based Compensation 3.62M 4.7M 4.73M 2.69M 572K 114K 187K 287K 279K 152K 116K
Other Working Capital 732K -2.81M 1.34M 873K -24K -8K -2.3M -973K -39K 30K 103K
Other Non-Cash Items 3.12M 7.62M 819K 805K 1.24M 1.43M 16.38M 6.76M 1.71M 5.22M -263K
Deferred Income Tax n/a -306K 148K -106K -247K 31K -554K 251K -14K 42K 42K
Change in Working Capital 325K 1.67M -61K -1.34M 174K -3.59M -2.02M -896K 1.68M 759K -446K
Operating Cash Flow -14.46M -32.14M -20.27M -14.08M -9.71M -9.3M -10.97M -11.9M -10.77M -6.87M -7.48M
Capital Expenditures -828K -4.32M -2.37M -455K -403K -199K -567K -805K -649K -172K -440K
Acquisitions n/a n/a n/a n/a 300K n/a 57K 5K n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a -2M n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a 2M n/a n/a n/a n/a n/a
Other Investing Acitivies 24K n/a -50K n/a 300K n/a 57K 5K n/a 721K -693K
Investing Cash Flow -804K -4.32M -2.42M -455K -103K -199K -510K -800K -649K 549K -1.13M
Debt Repayment -10.94M -696K -525K -249K -138K 4.96M 4.51M 10.75M 8.72M 7.4M -550K
Common Stock Repurchased 279K -239K n/a 142K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a -6.74M n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 306K 207K -3.94M 152K 18.42M 12.93M 25.52M -147K -635K 6.42M 7.8M
Financial Cash Flow -10.63M -489K 64.68M -97K 68.73M 11.42M 19.16M 10.61M 8.28M 11.31M 7.25M
Net Cash Flow -25.9M -36.95M 41.99M -14.64M 58.92M 1.92M 7.68M -2.1M -3.14M 5M -1.36M
Free Cash Flow -15.29M -36.46M -22.64M -14.54M -10.11M -9.5M -11.54M -12.71M -11.42M -7.04M -7.92M